In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog
In conclusion, SRJ09 successfully penetrated through DLD-1 MCL by diffusion and emerged as a potential candidate to be developed as a clinically viable anti-colon cancer drug.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Investigational New Drugs | Study